A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis

PETERS, D. E., NORRIS, L. D., TENORA, Lukáš, ŠNAJDR, Ivan, PONTI, A. K., ZHU, X., SAKAMOTO, S., VEERAVALLI, V., PRADHAN, M., ALT, J., THOMAS, A. G., MAJER, Pavel, RAIS, R., MCDONALD, C., SLUSHER, B. S. A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis. Science Translational Medicine. 2023, 15(708), eabn7491. ISSN 1946-6234. E-ISSN 1946-6242. Available: doi: 10.1126/scitranslmed.abn7491.